The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ibegbu, C. C.
Right arrow Articles by McDougal, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibegbu, C. C.
Right arrow Articles by McDougal, J. S.

The Journal of Immunology, Vol 142, Issue 7 2250-2256, Copyright © 1989 by American Association of Immunologists


ARTICLES

Structural features of CD4 required for binding to HIV

CC Ibegbu, MS Kennedy, PJ Maddon, KC Deen, D Hicks, RW Sweet and JS McDougal
Division of Host Factors, Centers for Disease Control, Atlanta, GA 30333.

A soluble form of the human CD4 glycoprotein (sCD4), the cellular receptor for human HIV, was treated with various physical, chemical, and enzymic regimens and tested over a range of concentrations for its capacity to inhibit the binding of HIV to CD4+ T cells. Reduction of disulfide bonds and alkylation in denaturing buffer (8 M urea) destroyed the inhibitory activity of sCD4, whereas reduction and alkylation in PBS had no effect. Derivatization or digestion of carbohydrate groups by periodate oxidation or by glycolytic enzyme digestion did not affect sCD4 inhibitory capacity. Digestion with trypsin or endoproteinase Glu-C destroyed activity. A limited digestion of sCD4 with endoproteinase Glu-C resulted in a mixture of fragments, however, and the mixture had inhibitory activity equivalent to that of intact sCD4. Within this mixture, a fragment of 23 kDa was identified that binds to HIV. Although sCD4 can be digested to yield fully active fragments, the requirement for intrachain disulfide bonding indicates that the minimum sized portion of CD4 that will retain full affinity for HIV will have to be formulated with a proper tertiary structure.


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
Md. I. Hassan, A. Waheed, S. Yadav, T. P. Singh, and F. Ahmad
Zinc {alpha}2-Glycoprotein: A Multidisciplinary Protein
Mol. Cancer Res., June 1, 2008; 6(6): 892 - 906.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
W.A. Hendrickson, P.D. Kwong, D.J. Leahy, S.-E. Ryu, H. Yamaguchi, S. Fleury, and R.-P. Sekaly
Structural Aspects of CD4 and CD8 Involvement in the Cellular Immune Response
Cold Spring Harb Symp Quant Biol, January 1, 1992; 57(0): 549 - 556.
[Abstract] [PDF]


Home page
ScienceHome page
P Lenert, D Kroon, H Spiegelberg, E. Golub, and M Zanetti
Human CD4 binds immunoglobulins
Science, June 29, 1990; 248(4963): 1639 - 1643.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.